Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 14;12(11):1544.
doi: 10.3390/brainsci12111544.

Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis

Affiliations
Review

Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis

Pien M M Weerkamp et al. Brain Sci. .

Abstract

Background: Intelligence scores in males with Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) remain a major issue in clinical practice. We performed a literature review and meta-analysis to further delineate the intellectual functioning of dystrophinopathies.

Method: Published, peer-reviewed articles assessing intelligence, using Wechsler Scales, of males with DMD or BMD were searched from 1960 to 2022. Meta-analysis with random-effects models was conducted, assessing weighted, mean effect sizes of full-scale IQ (FSIQ) scores relative to normative data (Mean = 100, Standard Deviation = 15). Post hoc we analysed differences between performance and verbal intelligence scores.

Results: 43 studies were included, reporting data on 1472 males with dystrophinopathies; with FSIQ scores available for 1234 DMD (k = 32) and 101 BMD (k = 7). DMD males score, on average, one standard deviation below average (FSIQ = 84.76) and significantly lower than BMD (FSIQ = 92.11). Compared to a previous meta-analysis published in 2001, we find, on average, significantly higher FSIQ scores in DMD.

Conclusion: Males with Duchenne have, on average, significantly lower FSIQ scores than BMD males and the general population. Clinicians must consider lower intelligence in dystrophinopathies to ensure good clinical practice.

Keywords: Wechsler Intelligence Scales; dystrophinopathies; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Figures

Figure 1
Figure 1
Flowchart of the selected articles.
Figure 2
Figure 2
Forest plot of full-scale intelligence scores in the DMD population. Abbreviations used: CI = confidence interval; p = significance level; SMD = standard mean difference; SD = standard deviation [10,13,24,26,41,96,97,98,99,101,102,103,104,107,108,109,110,113,114,115,117,118,121,122,123,124,125,126,127,128,129].
Figure 3
Figure 3
Forest plot of full-scale intelligence scores in the BMD population. Abbreviations used: CI = confidence interval; p = significance level; SMD = standard mean difference; SD = standard deviation [,,,,,,,].
Figure 4
Figure 4
Funnel plot of full-scale intelligence scores in the DMD population.
Figure 5
Figure 5
Funnel plot of full-scale intelligence scores in the BMD population.

References

    1. Birnkrant D.J., Bushby K., Bann C.M., Apkon S.D., Blackwell A., Colvin M.K., Cripe L., Herron A.R., Kennedy A., Kinnett K., et al. Diagnosis and management of Duchenne muscular dystrophy, part 3: Primary care, emergency management, psychosocial care, and transitions of care across the lifespan. Lancet Neurol. 2018;17:445–455. doi: 10.1016/S1474-4422(18)30026-7. - DOI - PMC - PubMed
    1. Waldrop M., Flanigan K.M. Update in Duchenne and Becker muscular dystrophy. Curr. Opin. Neurol. 2019;32:722–727. doi: 10.1097/WCO.0000000000000739. - DOI - PubMed
    1. Thangarajh M. The Dystrophinopathies. CONTINUUM Lifelong Learn. Neurol. 2019;25:1619–1639. doi: 10.1212/CON.0000000000000791. - DOI - PubMed
    1. Anderson J.L., Head S., Rae C., Morley J.W. Brain function in Duchenne muscular dystrophy. Brain. 2002;125:4–13. doi: 10.1093/brain/awf012. - DOI - PubMed
    1. Doorenweerd N., Hooijmans M., Schubert S.A., Webb A.G., Straathof C.S., van Zwet E.W., van Buchem M.A., Verschuuren J.J., Hendriksen J.G., Niks E.H., et al. Proton Magnetic Resonance Spectroscopy Indicates Preserved Cerebral Biochemical Composition in Duchenne Muscular Dystrophy Patients. J. Neuromuscul. Dis. 2017;4:53–58. doi: 10.3233/JND-160201. - DOI - PubMed

Grants and funding

LinkOut - more resources